KISSEI

  • Japanese Page

Change Font Size

  • normal
  • large
  • About Kissei
  • Research & Development
  • News Release
  • Investor Relations
  • Sustainability

About Kissei

Research & Development

News Release

Investor Relations

Sustainability

kissei

  • About Kissei
  • Research & Development
  • News Release
  • Investor Relations
  • Sustainability
  • Japanese Page
  • English
  • Message
  • Philosophy
  • Company Profile
  • Our Business
  • KISSEI's History
  • Corporate Governance
  • About R&D
  • Central Research Laboratories
  • Safety Research Laboratories
  • Joetsu Chemical Laboratories
  • Pharmaceutical Laboratories
  • R&D Pipeline
  • Financial results / Timely disclosure
  • Business Results
  • Annual Report
  • Shareholders Meeting
  • Sustainability Management
  • Materiality
  • Compliance
  • SDGs
  • Relationships with Society
  • Environmental Initiatives
  • Relationships with Our Employees
  • ESG Data
  • Message
  • Philosophy
  • Company Profile
  • Our Business
  • KISSEI's History
  • Corporate Governance
  • About R&D
  • Central Research Laboratories
  • Safety Research Laboratories
  • Joetsu Chemical Laboratories
  • Pharmaceutical Laboratories
  • R&D Pipeline
  • Financial results / Timely disclosure
  • Business Results
  • Annual Report
  • Shareholders Meeting
  • Sustainability Management
  • Materiality
  • Compliance
  • SDGs
  • Relationships with Society
  • Environmental Initiatives
  • Relationships with Our Employees
  • ESG Data
  • English Home
  • News Release
  • News Release(2006)

News Release(2006)

2006

  • October 30, 2006

    Glufast® (Generic Name: Mitiglinide), a Rapid-Acting Insulin Secretagogue, to be Launched in South Korea

  • May 10, 2006

    Launch of URIEF® Capsule, a Novel Drug for Dysuria associated with Benign Prostatic Hyperplasia

  • April 6, 2006

    Kissei and GlaxoSmithKline Signed License Agreement for KGA, a Novel Diabetic Medicine

  • January 23, 2006

    Kissei Acquired Marketing Approval for URIEF® Capsule, a Novel Drug for Dysuria associated with Benign Prostatic Hyperplasia

  • About Kissei
  • Research & Development
  • News Release
  • Investor Relations
  • Sustainability
  • Terms of Use
  • Privacy Policy
© 2012- Kissei Pharmaceutical Co., Ltd. All rights reserved.
キッセイ薬品工業株式会社

Back to top of page